trending Market Intelligence /marketintelligence/en/news-insights/trending/ovg3sg_uTwiArbFDvCEavg2 content esgSubNav
In This List

US FDA clears IRadimed's MRI-compatible IV infusion pump

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


US FDA clears IRadimed's MRI-compatible IV infusion pump

IRadimed Corp. received the U.S. FDA's 510(k) clearance for its MRidium 3860+ MRI-compatible IV infusion pump system, including its dose error reduction system software feature.

The system provides fluid delivery before, during and after an MRI scan. The dose error reduction system software allows users to create a unique drug library and set nominal values and limits for dose and concentration for specified infusion protocols.